Ildong Pharmaceutical Co., Ltd. (KRX:249420)

South Korea · Delayed Price · Currency is KRW

36,800

-850 (-2.26%)

Last updated: Feb 26, 2026, 10:34 AM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	614.94B	600.76B	637.71B	560.13B	561.85B
Pharmaceuticals Growth	2.36%	-5.80%	13.85%	-0.30%	8.58%
Total	614.94B	600.76B	637.71B	560.13B	561.85B
Total Growth	2.36%	-5.80%	13.85%	-0.30%	8.58%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Other	3.74B	3.28B	5.05B	4.48B	4.94B
Other Growth	14.11%	-35.07%	12.88%	-9.42%	4.00%
South Korea	605.43B	590.69B	623.12B	547.49B	545.30B
South Korea Growth	2.50%	-5.20%	13.81%	0.40%	7.54%
Japan	2.24B	3.77B	8.86B	3.41B	4.43B
Japan Growth	-40.57%	-57.42%	159.69%	-23.00%	13.78%
Southeast Asia	3.52B	3.01B	-	-	-
Southeast Asia Growth	16.93%	-	-	-	-
China	-	-	677.34M	4.75B	7.17B
China Growth	-	-	-85.75%	-33.74%	310.39%
Total	614.94B	600.76B	637.71B	560.13B	561.85B
Total Growth	2.36%	-5.80%	13.85%	-0.30%	8.58%

Source: S&P Global Market Intelligence.